Drug Shortage Report for MAXITROL

Last updated on 2019-02-05 History
Report ID 67487
Drug Identification Number 00042676
Brand name MAXITROL
Common or Proper name MAXITROL SUS 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXAMETHASONE POLYMYXIN B SULFATE NEOMYCIN
Strength(s) 1MG 6000UNIT 3.5MG
Dosage form(s) SUSPENSION
Route of administration OPHTHALMIC
Packaging size 5ML
ATC code S01CA
ATC description ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-11-16
Estimated end date 2019-02-04
Actual end date 2019-02-04
Shortage status Resolved
Updated date 2019-02-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-02-05 English Compare
v18 2019-02-04 French Compare
v17 2019-02-04 English Compare
v16 2019-02-01 French Compare
v15 2019-02-01 English Compare
v14 2019-01-30 French Compare
v13 2019-01-30 English Compare
v12 2019-01-25 French Compare
v11 2019-01-25 English Compare
v10 2019-01-09 French Compare
v9 2019-01-09 English Compare
v8 2018-12-18 French Compare
v7 2018-12-18 English Compare
v6 2018-12-11 French Compare
v5 2018-12-11 English Compare
v4 2018-11-30 French Compare
v3 2018-11-30 English Compare
v2 2018-11-23 French Compare
v1 2018-11-23 English Compare

Showing 1 to 19 of 19